Blair Anthony K

COO Blair Anthony K purchases 100,000 shares (100.0K) at $0.05; holds 1,000,000 shares post-transaction amid cluster buy

Blair Anthony K (COO) executed 2 purchases totaling 100,000 shares for $4,963.75 at $0.05 per share on May 21, 2025, increasing holdings from 900,000 to 1,000,000 shares (+11.1%). This purchase occurs within a cluster pattern: 2 other insiders also bought within the past 14 days, suggesting coordinated executive accumulation. The company carries significant challenges—net income of $-63,809,000.00 against quarterly revenue of $6,500,000.00—and trades -37.5% below its 52-week high despite 30-day price momentum of +4.6%. The COO's cross-ticker track record shows mixed outcomes (90-day average return -2.3%, win rate 33.33%), limiting confidence in this purchase as a directional signal. The clustering of multiple insider buys at depressed valuation warrants monitoring for underlying business developments or potential capital initiatives.

COO Blair Anthony K buys 500.0K shares of ZOM at $0.06 (total $30.0K); holdings climb 125% to 900.0K shares amid cluster of 7 other insider buys.

Blair Anthony K, the COO, purchased 500,000 shares at $0.06 on 2025-03-17, tripling his stake from 400,000 to 900,000 shares. This represents a substantial discretionary acquisition at a price 40% below the current market price of $0.10 and 67% below the 52-week high of $0.18. The purchase occurs within a documented cluster pattern: 7 other insiders have also bought within the past 14 days. However, the company remains unprofitable (net income of $-6.7M in the latest quarter) despite modest annual revenue growth of +8.3%, and the stock has declined 18.6% over the past 30 days and 22.7% over the past 90 days. His prior buys at ZOM show mixed timing results: 1 of 3 prior purchases generated positive 90-day returns, with the most recent November 2024 buy yielding a modest +2.4% in 30 days before declining -2.0% at the 90-day mark.

ZOM COO Blair buys 150,000 shares at $0.12; holds 400,000 post-trade (+60.0%); cluster of 3 other insider buys in 14 days

Blair Anthony K, as COO, purchased 150,000 shares of Zomedica at $0.12, increasing his holdings by 60.0% to 400,000 shares. The timing is notable: this is his third open-market purchase at ZOM in six months (prior buys on 2024-05-13 and 2024-08-20), and his May purchase achieved a +5.7% return over 90 days. The current filing occurs within a cluster pattern where 3 other insiders also bought within the past 14 days, suggesting coordinated conviction at current price levels. However, the company remains unprofitable ($-6.7M net income in the latest quarter) despite revenue growth of 33.0% year-over-year, and the stock is currently down 31.8% from its 52-week high of $0.22, creating a structural tension between insider accumulation and deteriorating fundamentals.

COO Blair Anthony K bought 100,000 shares of Zomedica at $0.14, raising holdings to 250,000 shares (+66.7%)

Blair Anthony K, the Chief Operating Officer, purchased 100,000 shares at $0.14 on 2024-08-20, increasing his holdings by 66.7% to 250,000 shares total. The stock is currently trading at $0.14, down 36.4% from its 52-week high of $0.22 and down 23.0% over the past 90 days. His prior buy at this ticker on 2024-05-13 achieved a 90-day return of +5.7%, indicating he has historically timed purchases at ZOM to precede subsequent gains. The company is unprofitable with a net income of $-23.9M in the latest fiscal year, though revenue is growing at 33.0% year-over-year. This substantial accumulation by the COO after recent price weakness, combined with his track record of well-timed purchases at this ticker, suggests conviction in the recovery prospects despite the company's current unprofitability and recent negative price momentum.